MedTrace Logo

Topical Corticosteroids on the Incidence of Postinflammatory Hyperpigmentation After QsNdYAG Laser

NCT02492373 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2016-06-01

No results posted yet for this study

Summary

To investigate the benefit of the application of topical high potency steroid on the incidence of post inflammatory hyperpigmentation after laser treatment.

Conditions

  • Lentigines
  • Post Inflammatory Hyperpigmentation

Interventions

DRUG

topical 0.05% Clobetasol propionate ointment

Apply only on the treated area twice a day as mentions

DEVICE

Q switched Nd:YAG laser 532 nm

Treatment of facial lentigines. The energy using depends on the endpoint of immediate whitening of the lesions.

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Woraphong Manuskiatti, M.D. · Department of Dermatology, Siriraj Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02492373 on ClinicalTrials.gov